The man who hopes to be President Donald Trump’s health secretary said he needed to see data showing vaccines are safe, but when an influential Republican senator did so, he dismissed it.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback